An assessment on intravenous magnesium sulphate on pain relief after abdominal hystrectomy
Phase 2
- Conditions
- Hysterectomy.Postprocedural disorder of genitourinary system, unspecified
- Registration Number
- IRCT2014012316325N1
- Lead Sponsor
- Vice Chancellor for Research, Guilan University of Medical Sciences-Rasht-Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 102
Inclusion Criteria
Inclusion Criteria:Age between 35-55; ASA I,II; No previous abdominal surgeries; systemic major cardiovascular diseases; musculoskeletal disorders; hepatic diseases; Calcium beta-blocker consumption; No previous renal insufficiency; nephropathy; myopathy; No allergy to Mg sulphate or other drugs; No drug abuse
Exclusion criteria: Surgeries which will lasted more than 1 hour
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain severity. Timepoint: 1-6-18-24 hours. Method of measurement: Visual Analog Scale(VAS).
- Secondary Outcome Measures
Name Time Method Adverse drug reaction. Timepoint: 1-6-18-24 hours. Method of measurement: History.;Pethidine consumption. Timepoint: 1-6-18-24 hours. Method of measurement: Whole pethidine dose usage.